	Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso. Int J Clin Pharm Sugaya S, Uchida M, Suzuki T, Kawakami E, Ishii I. PMID: 39570570 [PubMed - as supplied by publisher]
	The prognostic value of pretreatment [(18)F]FDG PET/CT parameters in esophageal cancer: a meta-analysis. Eur Radiol Huang M, Wang W, Wang R, Tian R. PMID: 39570366 [PubMed - as supplied by publisher]
	ADENOCARCINOMA AND DYSPLASIA IN BARRETT ESOPHAGUS: CRITICAL ANALYSIS OF RISK FACTORS AND SURVEILLANCE PROTOCOLS. Arq Bras Cir Dig Gallon E, Szachnowicz S, Duarte AF, Tustumi F, Sallum RAA, Herman P, Ribeiro Junior U. PMID: 39570180 [PubMed - indexed for MEDLINE]
	Risk of Cancer Diagnosis in Patients With Eosinophilic Esophagitis Using a Nationwide Swedish Population Cohort. United European Gastroenterol J Uchida AM, Schuman SS, Pyne A, Peterson K, Carlson M, Garber JJ, Roelstraete B, Ludvigsson JF. PMID: 39565026 [PubMed - as supplied by publisher]
	Esophageal melanosis: Two case reports and review of literature. World J Gastroenterol Kazacheuskaya L, Arora K. PMID: 39563752 [PubMed - indexed for MEDLINE]
	Helicobacter pylori, esophageal precancerous lesions, and proton pump inhibitor overuse. World J Gastroenterol Zhang F, Zhang H, Liu YM, Tang FS. PMID: 39563751 [PubMed - indexed for MEDLINE]
	Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study. Ther Adv Med Oncol Lin Y, Shen W, Ye J, Luo H, Zhang X, Xu Y, Lin Q, Liu W, Zhang Y, Xu Y, Jiang W, Zhao L, Liu A, Wu L, Ge H, Xie C, Zhao K, Chen J, Wang L, Liu Q. PMID: 39563718 [PubMed]
	Optimizing neoadjuvant radiotherapy for locally advanced esophageal squamous cell carcinoma: a comprehensive review on the role of concomitant or sequential immune checkpoint inhibitors. Esophagus Ghalehtaki R, Amini A, Abyaneh R. PMID: 39562407 [PubMed - as supplied by publisher]
	Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: A retrospective cohort study. PLoS One Jia W, Li C, Liu C, Hu R. PMID: 39561158 [PubMed - indexed for MEDLINE]
	Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment. Eur Rev Med Pharmacol Sci Teke Z, Bisgin A, Oruc Rencuzogullari C, Eren Erdogan K, Parsak CK, Kalkanli Tas S. PMID: 39560927 [PubMed - indexed for MEDLINE]
	Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study. Discov Oncol Liu J, Tang R, Zheng J, Luo K. PMID: 39560863 [PubMed]
	An Institutional Experience of Core Needle Biopsy with Cooperative Implementation by Pathologists and Head and Neck Oncologists in Salivary Gland Carcinoma. Head Neck Pathol Kobayashi K, Yoshimoto S, Omura G, Matsumoto Y, Sakai A, Eguchi K, Sakai T, Honma Y, Matsumoto F, Kawazu M, Saito Y, Ryo E, Yoshida A, Yatabe Y, Mori T. PMID: 39560855 [PubMed - indexed for MEDLINE]
	The diagnostic value of endoscopic ultrasound for esophageal subepithelial lesions: A review. Medicine (Baltimore) Li W, Shao M, Hu S, Xie S, He B. PMID: 39560558 [PubMed - indexed for MEDLINE]
	Study on the mechanism of hyperoside in affecting the biological progression and radiosensitivity of esophageal carcinoma by modulating the STAT3/AKT/ERK pathway. Biomol Biomed Yin H, Zheng Y, Yuan Z, Han X, Jiang D, Li D, Song F. PMID: 39558814 [PubMed - as supplied by publisher]
	A comparison between single and fractionated doses of albumin-bound paclitaxel in the treatment of advanced esophageal cancer: A multicenter case-control study. Sci Prog Ren J, Wang K, Zhao J, Xu C, Liu C, Wang Y, Wang G. PMID: 39558764 [PubMed - indexed for MEDLINE]
	Central ligation or partial preservation of the right gastric artery does not seem to affect conduit or anastomotic perfusion during robot-assisted resection of gastroesophageal junction cancer: a randomized clinical trial. Dis Esophagus Osterkamp JTF, Nerup N, Svendsen MBS, Strandby RB, Svendsen LB, Aasvang EK, Vad H, Plamboeck A, Achiam MP. PMID: 39558692 [PubMed - as supplied by publisher]
	Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma. BMC Cancer Li T, Dai Y, Fu X, Cai Q, Ke D, Yao Q, Li J. PMID: 39558325 [PubMed - indexed for MEDLINE]
	Prediction of esophageal fistula in radiotherapy/chemoradiotherapy for patients with advanced esophageal cancer by a clinical-deep learning radiomics model : Prediction of esophageal fistula in radiotherapy/chemoradiotherapy patients. BMC Med Imaging Zhang Y, Cheng X, Luo X, Sun R, Huang X, Liu L, Zhu M, Li X. PMID: 39558242 [PubMed - indexed for MEDLINE]
	Multimodality Therapy and Survival Outcomes in Resectable Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective Study. Ann Surg Oncol Xu L, Yang YS, Li B, Cao YQ, Lin SY, Yu YK, Xie HN, Li HM, Yuan Y, Chen XK, Li Y, Qin JJ, Zhang L, Liu XB, Tan LJ, Li HC, Xiang JQ, Chen LQ, Zhang RX, Li Y. PMID: 39557721 [PubMed - as supplied by publisher]
	Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, Giuliani F, Morano F, Niger M, Raimondi A, Prisciandaro M, Pircher CC, Sciortino C, Marchesi S, Garattini SK, Airò G, Miceli R, Di Bartolomeo M, Pietrantonio F. PMID: 39557058 [PubMed - as supplied by publisher]

Articles 1 - 20 / 35161

Page 1 of 1759



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy